Diversity of β-lactamases in pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals

Microbial Drug Resistance

Volumn 17, Issue 1, 2011, Pages 25-30

  Ktari, Sonia ^a   Mnif, Basma ^a   Znazen, Abir ^a   Rekik, Manel ^a   Mezghani, Sonda ^a   Mahjoubi Rhimi, Fouzia ^a   Hammami, Adnane ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG; VIM 2 BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; ENZYME SYNTHESIS; GENETIC VARIABILITY; GENETICS; HOSPITAL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; TUNISIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TUNISIA;

PSEUDOMONAS AERUGINOSA;

EID: 79952413622     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0104     Document Type: Article

References (41)

1. Bert, F., C. Branger, and N. Lambert-Zechovsky. 2002. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18. (Pubitemid 34785249)
2. Cavallo, J. D., H. Chardon, C. Chidiac, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, B. Guery, V. Jarlier, T. Lambert, R. Leclercq, M. H. Nicolas-Chanoine, C. Quentin, B. Rouveix, C. J. Soussy, and E. Varon. 2007. Comité de l'antibiogramme de la société française de microbiologie. Recommandations. Available at: www.sfm.asso.fr. (Online).
3. Dallenne, C., A. Da Costa, D. Decré, C. Favier, and G. Arlet. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Antimicrob. Agents Chemother. 65:490-495.
4. Docquier, J. D., F. Luzzaro, G. Amicosante, A. Toniolo, and G. M. Rossolini. 2001. Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serinebeta-lactamase and VIM-2 metallo-beta-lactamase. Emerg. Infect. Dis. 7:910-911. (Pubitemid 33121607)
5. Empel, J., K. Filczak, A. Mro'wka, W. Hryniewicz, D. M. Livermore, and M. Gniadkowski. 2007. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum β-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J. Clin. Microbiol. 45:2829-2834. (Pubitemid 47417322)
6. Giske, C. G., B. Libisch, C. Colinon, E. Scoulica, L. Pagani, M. Füzi, G. Kronvall, and G. M. Rossolini. 2006. Establishing clonal relationships between VIM-1-like metallobeta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J. Clin. Microbiol. 44:4309-4315. (Pubitemid 44937057)
7. Gutiérrez, O., C. Juan, E. Cercenado, F. Navarro, E. Bouza, P. Coll, J. L. Pérez, and A. Oliver. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335. (Pubitemid 350209885)
8. SHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin. Microbiol. Infect. 16:189-193.
9. Hocquet, D., P. Plésiat, B. Dehecq, P. Mariotte, D. Talon, and X. Bertrand; ONERBA. 2010. Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France. Antimicrob. Agents Chemother. 54:3512-3515.
10. Kad., C. I. and S. T. Liu. 1981. Rapid procedure for detection and isolation of a large and small plasmids. J. Bacteriol. 145:1365-1373.
11. Kalai Blagui, S., W. Achour, M. S. Abbassi, M. Bejaoui, A. Abdeladhim, and A. Ben Hassen. 2007. Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia. Clin. Microbiol. Infect. 13:794-800. (Pubitemid 47039913)
12. Ktari, S., G. Arlet, B. Mnif, V. Gautier, F. Mahjoubi, M. Ben Jmeaa, M. Bouaziz, and A. Hammami. 2006. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC betalactamase in a Tunisian university hospital. Antimicrob. Agents Chemother. 50:198-201.
13. Lauretti, L., M. L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590. (Pubitemid 29331232)
14. Lee, S., Y. J. Park, M. Kim, H. K. Lee, K. Han, C. S. Kang, and M. W. Kang. 2005. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J. Antimicrob. Chemother. 56:122-127. (Pubitemid 41418345)
15. Libisch, B., L. Poirel, Z. Lepsanovic, V. Mirovic, B. Balogh, J. Paszti, Z. Hunyadi, A. Dobak, M. Fuzi, and P. Nordmann. 2008. Identification of PER-1 extended-spectrum β-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol. Med. Microbiol. 54:330-338.
16. Libisch, B., J. Watine, B. Balogh, M. Gacs, M. Muzslay, G. Szabó, and M. Füzi. 2008. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res. Microbiol. 159:162-168.
17. Mansour, W., S. Dahmen, L. Poirel, K. Charfi, D. Bettaieb, N. Boujaafar, O. Bouallegue. 2009. Emergence of SHV-2a extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a university hospital in Tunisia. Microb. Drug Resist. 15:295-301.
18. Mansour, W., L. Poirel, D. Bettaieb, O. Bouallegue, N. Boujaafar, and P. Nordmann. 2009. metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolates in Tunisia. Diagn. Microbiol. Infect. Dis. 64:458-461.
19. Mirsalehian, A., M. Feizabadi, F. A. Nakhjavani, F. Jabalameli, H. Goli, and N. Kalantari. 2010. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum betalactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns 36:70-74.
20. VIM-2 metallo-beta-lactamase genes among genetically unrelated Pseudomonas aeruginosa isolates in a South Korean hospital. Int. J. Antimicrob. Agents 31:586-588.
21. Nordman., P. and M. Guibert. 1998. Extended-spectrum β-lactamases in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 42:128-131.
22. Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969. (Pubitemid 23141304)
23. Pallecchi, L., M. L. Riccio, J. D. Docquier, R. Fontana, and G. M. Rossolini. 2001. Molecular heterogeneity of blaVIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase. FEMS Microbiol. Lett. 195:145-150. (Pubitemid 32155369)
24. Patzer, J. A., T. R. Walsh, J. Weeks, D. Dzierzanowska, and M. A. Toleman. 2009. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. J. Antimicrob. Chemother. 63:269-273.
25. Picão, R. C., L. Poirel, A. C. Gales, and P. Nordmann. 2009. Diversity of beta-lactamases produced by ceftazidimeresistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob. Agents Chemother. 53:3908-3913.
26. Pitout, J. D., G. Revathi, B. L. Chow, B. Kabera, S. Kariuki, P. Nordmann, and L. Poirel. 2008. metallo-beta-lactamaseproducing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin. Microbiol. Infect. 14:755-759.
27. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing). metallo β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897. (Pubitemid 30165266)
28. Poirel, L., V. O. Rotimi, E. M. Mokaddas, A. Karim, and P. Nordmann. 2001. VEB-1-like extended-spectrum betalactamases in Pseudomonas aeruginosa, Kuwait. Emerg. Infect. Dis. 7:468-470.
29. Poirel, L., G. F. Weldhagen, C. de Champs, and P. Nordmann. 2002. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum b-lactamase GES-2 in South Africa. J. Antimicrob. Chemother. 49:561-565. (Pubitemid 34223682)
30. VIM-4. J. Antimicrob. Chemother. 51:1409-1414. (Pubitemid 36748930)
31. Sacha, P., P. Wieczorek, T. Hauschild, M. Zórawski, D. Olszańska, and E. Tryniszewska. 2008. metallo-beta-lactamases of Pseudomonas aeruginosa-a novel mechanism resistance to beta-lactam antibiotics. Folia Histochem. Cytobiol. 46:137-142.
32. Strateva, T., V. Ouzounova-Raykova, B. Markova, A. Todorova, Y. Marteva-Proevska, and I. Mitov. 2007. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J. Med. Microbiol. 56:956-963. (Pubitemid 47047490)
33. Takahashi. S., and Y. Nagano. 1984. Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J. Clin. Microbiol. 20:608-613. (Pubitemid 14006045)
34. Uemura, S., S. I. Yokota, H. Mizuno, E. Sakawaki, K. Sawamoto, K. Maekawa, K. Tanno, K. Mori, Y. Asai, and N. Fujii. 2010. Acquisition by Pseudomonas aeruginosa isolates of a transposon encoding an extended-spectrum {beta}-lactamase SHV-12 during the clinical course of a burn patient. Antimicrob. Agents Chemother. 54:3956-3959.
35. Vahaboglu, H., R. Ozturk, H. Akbal, S. Saribas, O. Tansel, and F. Coskunkan. 1998. Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum β-lactamases. J. Clin. Microbiol. 36:827-829. (Pubitemid 28093278)
36. Vahaboglu, H., R. Oztürk, G. Aygün, F. Coşkunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum b-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicentre study. Antimicrob Agents Chemother. 41:2265-2269. (Pubitemid 27422224)
37. Valenza, G., B. Joseph, J. Elias, H. Claus, A. Oesterlein, K. Engelhardt, D. Turnwald, M. Frosch, M. Abele-Horn, and C. Schoen. 2010. First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrob. Agents Chemother. 54:3493-3497.
38. Walsh, T. R., M. A. Toleman, W. Hryniewicz, P. M. Bennett, and R. N. Jones. 2003. Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother. 52:116-119. (Pubitemid 36850096)
39. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. metallobeta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
40. Weldhagen, G. F., L. Poirel, and P. Nordmann. 2003. Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392. (Pubitemid 36919434)
41. Yakupogullari, Y., L. Poirel, S. Bernabeu, A. Kizirgil, and P. Nordmann. 2008. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum betalactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. J. Antimicrob. Chemother. 61:221-222.